CRISPR Therapeutics AG (CRSP Quick QuoteCRSP - Free Report) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, CRSP crossed above the 20-day moving average, suggesting a short-term bullish trend.

The 20-day simple moving average is a popular trading tool. It provides a look back at a stock's price over a 20-day period, and is beneficial to short-term traders since it smooths out price fluctuations and provides more trend reversal signals than longer-term moving averages.

The 20-day moving average can show signals that are similar to other SMAs as well. If a stock's price is moving above the 20-day, the trend is considered positive. When the price falls below the moving average, it can signal a downward trend.

Shares of CRSP have been moving higher over the past four weeks, up 5.1%. Plus, the company is currently a Zacks Rank #2 (Buy) stock, suggesting that CRSP could be poised for a continued surge.

Looking at CRSP's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 2 revisions higher for the current fiscal year compared to none lower, and the consensus estimate has moved up as well.

Investors should think about putting CRSP on their watchlist given the ultra-important technical indicator and positive move in earnings estimate revisions.